Human Microbiome Therapeutics
Light Lab: Understanding the gut microbiome to treat disease
Human Microbiome Market Size to Surge to $4.85 Billion by 2031, Fuelled by Research and Innovation - Exclusive Report by The Insight Partners
Human microbiome market to reach $4.85b by 2031
Intratumor microbiome's influence on lung cancer: A single-cell perspective
Exploring the World of Bacterial Genomes with Novel Sequencing Methods
Rebiotix microbiome drug success against C diff infection
Microbiotica unveils data on the mechanism of action of MB310, a clinical-stage drug candidate in development for the treatment of ulcerative colitis
Microbiome study finds bacteria in human gut rarely update their CRISPR defense systems
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Microbiome
The vaginal symptoms you should never ignore — and why you should worry about your microbiome
What Happens When Vaginal Microbiome Is Imbalanced?
Gut microbiome changes linked to multiple sclerosis, study finds
Why Is Microbiome Health Vital for Pregnancy and Menstrual Health?
Stress Eating and the Microbiome
A shocking link between gut bacteria and Alzheimer’s
New Research Uncovers How Yogurt’s Probiotics May Help Reduce Cancer Risk
Meet APOLLO: Researchers Create World’s Largest Digital Microbe Collection
4 oral bacteria linked to Alzheimer’s risk breakthrough
Milk boosts gut-friendly bacteria while cheese alters microbiome balance, study reveals
Human Microbiome
Intratumor microbiome's influence on lung cancer: A single-cell perspective
Meet APOLLO: Researchers Create World’s Largest Digital Microbe Collection
Why Is Microbiome Health Vital for Pregnancy and Menstrual Health?
Light Lab: Understanding the gut microbiome to treat disease
Trust your gut: The ins and outs of your gut microbiome
Scientists track diet through stool DNA, revealing a new way to monitor nutrition
4 oral bacteria linked to Alzheimer’s risk breakthrough
Researchers create digital microbe collection to transform health research
Microbiotica unveils data on the mechanism of action of MB310, a clinical-stage drug candidate in development for the treatment of ulcerative colitis
Microbiome Therapeutics
From microbes to medicines
Light Lab: Understanding the gut microbiome to treat disease
Seven companies using metabolomics to decode biology
Microbiome drug gets Breakthrough Therapy status
Human Microbiome Market Size to Surge to $4.85 Billion by 2031, Fuelled by Research and Innovation - Exclusive Report by The Insight Partners
6th Microbiome Movement - Drug Development Summit
Exploring the World of Bacterial Genomes with Novel Sequencing Methods
CJ Bioscience to Present Preclinical Data on Inflammatory Bowel Disease Pipeline Candidate CJRB-201 at 'ECCO 2025'; Clinical Entry Targeted for 2026
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Human Microbiome Market Size to Surge to $4.85 Billion by 2031, Fuelled by Research and Innovation - Exclusive Report by The Insight Partners
